No name

Did you know that schizophrenia affects more than 1 percent of the world's population?

See NARSAD Grants at work on the latest schizophrenia research

Schizophrenia is a severe, chronic, and generally disabling brain and behavior disorder. It is most accurately described as a psychosis - a type of illness that causes severe mental disturbances that disrupt normal thoughts, speech, and behavior. Schizophrenia is believed to be caused by a combination of genetic and environmental factors.

Positive symptoms may include delusions, thought disorders, and hallucinations. People with schizophrenia may hear voices other people don't hear, or believe other people are reading their minds, controlling their thoughts, or plotting to harm them. Negative symptoms may include avolition (a lack of desire or motivation to accomplish goals), lack of desire to form social relationships, and blunted affect and emotion. Cognitive symptoms involve problems with attention and memory, especially in planning and organization to achieve a goal. Cognitive deficits are the most disabling for patients trying to lead a normal life.

learn more about schizophrenia

Visit the Schizophrenia Research Forum, fully sponsored by the Brain & Behavior Research Foundation—a virtual community of scientists collaborating in their quest for causes, improved treatments, and better understanding of schizophrenia.

Visit the Schizophrenia Research Forum for more information about research

 

Linda Carpenter, M.D., Chief of the Mood Disorders Program and the Neuromodulation Clinic at Butler Hospital in Providence, Rhode Island, NARSAD Young Investigator Grant, expert in depression
Linda Carpenter, M.D.
July 31, 2012
NARSAD Grantee Linda Carpenter, M.D., is the lead author of a newly published study that demonstrates for the first time that transcranial magnetic stimulation...
Peter C. Whybrow, M.D., Director of the Semel Institute for Neuroscience and Human Behavior at the University of California in Los Angeles
Peter C. Whybrow, M.D.
July 26, 2012
In an article that was the cover story of the July 16 issue of Newsweek, NARSAD Grantee Peter C. Whybrow, M.D., Director of the Semel Institute for...
Karl Deisseroth, M.D., Ph.D., of Stanford University
Karl Deisseroth, M.D., Ph.D.
July 24, 2012
Brain and behavior disorders are increasingly considered to be caused by altered functioning in the circuitry of the brain. Now known to be a vast and...
Fred H. Gage, Ph.D., Professor, Laboratory of Genetics, Salk Institute Expert on Depression
Fred H. Gage, Ph.D.
July 24, 2012
Two Brain & Behavior Research Foundation Scientific Council Members have announced promising results of clinical trials of a ketamine-alternative called...
Mikhail V. Pletnikov, M.D., Ph.D., associate professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine, expert on schizophrenia
Mikhail Pletnikov, M.D., Ph.D.
July 20, 2012
In a new study published in the journal Molecular Psychiatry, Johns Hopkins researchers have discovered that two previously established biological risk factors...

Pages

Subscribe to